FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live CIPLA message board: Is CIPLA buy or sell? Should I buy CIPLA shares? Why are CIPLA shares falling? Should I invest in CIPLA stock?
forum
CIPLA Share Price Discussion
Cipla Ltd.
NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Sector: Pharmaceuticals and health care
N
Reputation: 4,817 • Jun 8 1:08 AM
A Bangladesh pharma company causes heartburn in India's drugmakers
Eskayef Pharma had been quick to take advantage of international trade rules that allow nations defined by the United Nations as least-developed countries to ignore patents and produce affordable drugs.
Eskayef Pharma had been quick to take advantage of international trade rules that allow nations defined by the United Nations as least-developed countries to ignore patents and produce affordable drugs.
Moneycontrol
Like
Reply
NSE:CIPLA price when posted: 636.1
Recent posts in CIPLA
N
Reputation: 4,817 • Today 2:03 AM
Covid-19 vaccine: Cipla scales up manufacturing of remdesivir to meet high demand
Besides remdesivir, tocilizumab that Cipla markets under licensing pact with Swiss pharma company Roche is also seeing huge demand
Besides remdesivir, tocilizumab that Cipla markets under licensing pact with Swiss pharma company Roche is also seeing huge demand
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 1:56 AM
India's shortage of remdesivir is easing, to ramp up production: Producer Cipla
Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations.
Remdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are authorised to make and sell generic versions in 127 developing nations.
The Economic Times
Like
Reply
N
Reputation: 4,817 • Today 12:43 PM
Buy Cipla; target of Rs 805: HDFC Securities
HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 805 in its research report dated August 10, 2020.
HDFC Securities is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 805 in its research report dated August 10, 2020.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 12:43 PM
Neutral Cipla; target of Rs 790: Motilal Oswal
Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 790 in its research report dated August 08, 2020.
Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 790 in its research report dated August 08, 2020.
Moneycontrol
Like
Reply
N
Reputation: 4,817 • Today 9:58 AM
Reduce Cipla; target of Rs 657: Prabhudas Lilladher
Prabhudas Lilladher recommended reduce rating on Cipla with a target price of Rs 657 in its research report dated August 09, 2020.
Prabhudas Lilladher recommended reduce rating on Cipla with a target price of Rs 657 in its research report dated August 09, 2020.
Moneycontrol
Like
Reply